Granted Patent B2

US 8,871,263 · App. 12/887,544 · Granted Oct 28, 2014

Abstract

Claims (25)

1. A process for making a tablet comprising compacting a powder blend in a die platen of an apparatus to form a tablet shape, wherein said powder blend comprises a pharmaceutically active agent and a meltable binder, and applying radiofrequency energy from said apparatus to said tablet shape within said die platen for a sufficient period of time to soften or melt said binder within said tablet shape to form said tablet; wherein said process comprises the steps of:

(i) introducing said powder blend into a forming cavity within said die platen;

(ii) compacting said powder blend by introducing at least one forming tool into said die platen with sufficient force such that a tablet shape is formed;

(iii) applying said radiofrequency energy to said tablet shape within said forming cavity to form said tablet wherein said at least one said forming tool or said die platen emits said radiofrequency energy to said tablet shape; and

(iv) removing said tablet from said forming cavity.

2. The process of claim 1 , wherein said binder is a RF-meltable binder having a melting point of from about 40° C. to about 140° C.

3. The process of claim 1 , wherein said RF-meltable binder is polyethylene glycol.

4. The process of claim 1 , wherein said powder blend comprises from about 0.01 to about 30 percent, by weight, of said pharmaceutically active agent and from about 1 to about 30 percent, by weight, of said meltable binder.

5. The process of claim 1 , wherein said powder blend further comprises one or more carbohydrates selected from the group consisting of dextrose monohydrate, mannitol, erythritol, dextrose, lactose, sorbitol, isomalt, sucrose, dextrates and maltodextrins.

6. The process of claim 1 , wherein said powder blend comprises from about from about 30 to about 95 percent, by weight, of one or more carbohydrates.

7. The process of claim 1 , wherein said powder blend is compacted with a force less than 0.3 kiloNewtons.

8. The process of claim 1 , wherein said radiofrequency energy has a frequency of from about 1 MHz to 100 MHz.

9. The process of claim 1 , wherein said powder blend has an average particle size of less than 500 microns.

10. The process of claim 1 , wherein said tablet disintegrates in the mouth when placed on the tongue in less than about 30 seconds.

11. The process of claim 1 , wherein said tablet meets the criteria for orally disintegrating tablets as defined by the draft Food & Drug Administration guidance, as published April, 2007.

12. The process of claim 1 , wherein said tablet has a hardness of less than 700 grams as measure using Texture Analyzer TA-XT2i that is fitted with a 7 millimeter diameter flat faced probe.

13. The process of claim 1 , wherein said tablet has a density less than 0.8 g/cc.

14. The process of claim 4 , wherein said process further comprises the step of cooling said tablet in said die prior to removing said tablet from said die.

15. The process of claim 2 , wherein said at least one said forming tool emits said radiofrequency energy to said tablet shape.

16. The process of claim 2 , wherein the die platen emits said radiofrequency energy to said tablet shape.

17. The process of claim 1 , wherein said powder blend is compacted using an upper forming tool and a lower forming tool, and at least one of said upper forming tool or lower forming tool emits said radiofrequency energy to said tablet shape.

18. The process of claim 1 , wherein the surface of said tablet is further exposed to infrared energy wherein the majority of the wavelength of said infrared energy from about 0.5 to about 5 micrometers.

19. A tablet manufactured according to the process of claim 1 .

20. The process of claim 1 , wherein said at least one said forming tool emits said radiofrequency energy to said tablet shape.

21. The process of claim 7 , wherein said at least one said forming tool emits said radiofrequency energy to said tablet shape.

Assignments (8)